article thumbnail

Canada: J&J’s Janssen Denied Data Protection Rights For Ketamine Analog Spravato In Canada, Court Rules ‘Not An Innovative Drug’

Cannabis Law Report

The Federal Court of Appeals in Canada ratified a Ministry of Health decision to refuse to provide J anssen Pharmaceuticals, a subsidiary of Johnson and Johnson (NYSE: JNJ ), data protection for Spravato, a ketamine analog approved for depression. What Is Data Protection And Why Is It Important? and Canada. What Happened?

Data 98
article thumbnail

Nonprofits Team Up in the Battle Against Epilepsy in Children

Medical Marijuana Program Connection

–(BUSINESS WIRE)–Beginning in January 2024, natural medicine research nonprofits Realm of Caring, Unlimited Sciences and Lily’s Lighthouse will collaborate to collect data for an observational study on the efficacy of functional mushrooms in treating epilepsy. COLORADO SPRINGS, Colo.–(BUSINESS

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Report: Gen Z Would Rather Smoke Cannabis Than Consume Alcohol

Veriheal

California was the first state to legalize medicinal cannabis in 1996, right around the time that Gen Z began to enter society. Alternative medicines are a priority among Gen Z, who are moving away from traditional Western options and instead using natural wellness to support the mind and body.

article thumbnail

Argentina Presents Cannabis, Hemp Industry Bill

Cannabis Law Report

.” Kulfas’ presentation began with some hard data, giving an account of the importance of regulating the activity in Argentina. ley cáñamo argentina.

Hemp 105
article thumbnail

WA’s Cannabis Employment Protections, Psilocybin-Color Blindness Case Study, & Ketamine’s Rise Explained

Veriheal

The case report built off data self-study complied by an Institute colleague and combined it with past reports of colorblind individuals who experienced vision improvements after consuming psilocybin. Test data showed that the subject experienced peak partial vision improvement around eight days after consuming psilocybin.

article thumbnail

RYAH Medtech Inc. Completes Initial Shipment for Major UK-based Clinical Trial

Cannabis Law Report

Given the size and scale of the study, RYAH has developed a custom software solution, using OAuth API-integration to protect the privacy of the participants in the study, with the goal of enabling a fully integrated, patient feedback and data collection capability. billion, servicing nearly 340,000 active patients. About RYAH Group, Inc.

article thumbnail

Australia: Medicinal cannabis firm Greenfield MC Global turns to crowdfunding for expansion

Cannabis Law Report

Despite strong prescription growth in Australia and inroads in many jurisdictions abroad, not to mention recreational cannabis legalisation in Canberra which paradoxically may be a threat to the sector , weak investor sentiment has been a tough pill to swallow for medicinal cannabis companies on the ASX. million. .